Kadmon Holdings Inc. (KDMN) |
|
4.73 0.15 (3.28%)
|
07-07 16:00 |
|
Open: |
4.56 |
Pre. Close: |
4.58 |
|
High:
|
4.9 |
Low:
|
4.5393 |
|
Volume:
|
2,125,601 |
Market Cap:
|
757M |
|
|
|
|
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.911 - 4.944 |
4.944 - 4.973 |
|
Low:
|
4.463 - 4.503 |
4.503 - 4.539 |
|
Close:
|
4.668 - 4.731 |
4.731 - 4.789 |
|
Technical analysis |
as of: 2020-07-07 4:35:55 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 5.84 One year: 6.42 |
| Support: |
Support1: 4.18 Support2: 3.48 |
| Resistance: |
Resistance1: 5.00 Resistance2: 5.50 |
| Pivot: |
4.89 |
| Moving Average: |
MA(5): 4.79  MA(20): 4.82
MA(100): 4.36 MA(250): 3.78 |
| MACD: |
MACD(12,26): 0.08 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 26.49 %D(3): 33.43 |
| RSI: |
RSI(14): 49.16 |
| 52-week: |
High: 5.50 Low: 2.04 Change(%): 100.4 |
| Average Vol(K): |
3-Month: 250423 10-Days: 314796 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.KDMN has closed above bottom band by 34.6%. Bollinger Bands are 12.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 06 Jul 2020
Kadmon Holdings, Inc. (KDMN) At $4.81: It’s Worth Your Interest - Stocks Register
Mon, 06 Jul 2020
Kadmon Holdings Inc. (KDMN) return on Assets touches -32.08: These Shares are Poised for Major Movement - News Daemon
Wed, 01 Jul 2020
Kadmon Holdings, Inc. (KDMN) and the Battle of Fundamental vs. Technical - The News Heater
Tue, 30 Jun 2020
When Will Kadmon Holdings, Inc. (NYSE:KDMN) Breakeven? - Simply Wall St
Mon, 29 Jun 2020
Learn Why Kadmon Holdings, Inc. (KDMN) Has Been Active In the Market Recently - Invest Million
Thu, 25 Jun 2020
Kadmon Holdings, Inc. (KDMN): Skating on Thin Ice? Beta Stands at 1.47 - The News Heater
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
160 |
| Shares Float (M) |
110 |
|
% Held by Insiders
|
0.16 |
|
% Held by Institutions
|
83.14 |
|
Shares Short (K)
|
19,290 |
|
Shares Short P. Month (K)
|
20,150 |
Stock Financials |
|
EPS
|
-0.690 |
|
EPS Est This Year
|
-1.550 |
|
EPS Est Next Year
|
-1.750 |
|
Book Value (p.s.)
|
0.600 |
|
Profit Margin
|
|
|
Operating Margin
|
-701.10 |
|
Return on Assets (ttm)
|
-27.1 |
|
Return on Equity (ttm)
|
-72.0 |
|
Qtrly Rev. Growth
|
9952.2 |
|
Gross Profit (p.s.)
|
0.024 |
|
Sales Per Share
|
0.074 |
|
EBITDA (p.s.)
|
-0.508 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-76 |
|
Levered Free Cash Flow (M)
|
-46 |
Stock Valuations |
|
PE Ratio
|
-6.86 |
|
PEG Ratio
|
|
|
Price to Book value
|
7.88 |
|
Price to Sales
|
64.29 |
|
Price to Cash Flow
|
-9.98 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
